Medicare

The 12 Million People Lost in a Maze of Medicare and Medicaid

Many of America’s poorest and sickest patients are stuck navigating two separate insurance programs — Medicare and Medicaid — to get the care they need.

Read More

What to Expect When Medicare and Pharma Finally Negotiate Drug Prices

We explain how Medicare’s historic price negotiations with drugmakers will work, and the impact they could have.

Read More

Can Medicare Afford to Foot the Bill for New Alzheimer’s Drugs?

Recent analyses in JAMA and by the Kaiser Family Foundation raise questions about whether Medicare and its beneficiaries can afford a new wave of Alzheimer’s treatments.

Read More

One Economist’s Plan to Blow Up America’s Health Insurance System

Amy Finkelstein outlines an evidence-based plan to overhaul our patchwork of health insurance policies.

Read More

The Meteoric Rise of Private Medicare Advantage Insurance

What’s gained and what’s lost as private insurers manage an increasingly large share of the Medicare program?

Read More

The Wonky Policy That’s Got Hospitals on High Alert

Medicare could soon pay hospitals much less for common outpatient services like x-rays and checkups.

Read More

Hospice Care’s Midlife Crisis

Medicare is testing some major changes to its 40-year-old hospice benefit.

Read More

When Home Becomes a Hospital

What have we learned from the pandemic-feuled expansion of hospital-at-home care?

Read More

How a Medicare Payment Fix Could Worsen Disparities

A potential change to reduce upcoding in Medicare could worsen health disparities.

Read More

Medicare Director Meena Seshamani on CMS’ New Drug Pricing Powers

Medicare director Meena Seshamani discusses her team’s sprint to put historic drug price reforms into action.

Read More